Preparation of Bfgf-Plga Sustained Release Microspheres and Studies on Their Release Characteristics and Biologic Activity in Vitro

段宏,沈彬,何勤,裴福兴,陈坚
DOI: https://doi.org/10.3321/j.issn:1001-2494.2004.03.012
2004-01-01
Abstract:OBJECTIVE To prepare bFGF-PLGA microspheres (bFGF-PLGA -Ms) and investigate their general properties, in vitro drug release characteristics and biologic activity of bFGF released from the microspheres. METHODS The bFGF-PLGA microspheres were prepared by w/o/w multiple emulsion volatilizing method. Their general properties were observed. To measure the content of bFGF, ELISA method was used and the regression equation was established. The bFGF-PLGA -Ms were kept in 0.9% sodium chloride solution to study their in vitro release characteristics. The proliferation of the cultured fibroblast was measured with MTT method after bFGF-PLGA -Ms being added to the DMEM culture medium. RESULTS The bFGF-PLGA-Ms were good, even and uniform spheres with mean particle size of (1.552±0.015)μm. The lyophilized powder was pure white with good dispority. Its critical humidity was 64%. The content of CH 2Cl 2 was less than 1/10 of the limited value. The drug loading amount and encapsulation efficiency of bFGF-PLGA-Ms were [(27.18±0.51)×10 -3 ]% and (66.43±1.24)% respectively. The in vitro release profile of bFGF-PLGA -Ms was figured by Higuichi equation: Q =25.884?6 t 1/2 -15.705?1 ( r =0.997?5). The drug release rate was only 19.26% during the burst release phase and rose to 72.47% at the 11th day. 2 and 3 days after plate culturing, the absorption values at 490 nm of bFGF group were much higher than those of the bFGF-PLGA-Ms group and the PLGA group; 4 to 6 days after plate culturing, the A values of bFGF-PLGA -Ms group was the highest among the three groups. CONCLUSION The bFGF-PLGA-Ms and their lyophilized powder have excellent pharmaceutical properties showing sustained release effect in vitro with good biological activity.
What problem does this paper attempt to address?